OPKO Health Inc. | Income Statement

Fiscal year is January-December. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
97
91
500
1,222
1,068
990
Cost of Goods Sold (COGS) incl. D&A
60
59
263
676
705
673
Gross Income
37
32
237
546
363
318
SG&A Expense
108
144
298
587
633
479
EBIT
72
112
-
41
270
161
Unusual Expense
52
46
51
34
9
7
Non Operating Income/Expense
33
2
9
9
10
2
Interest Expense
14
12
8
7
7
12
Pretax Income
104
171
138
74
276
177
Income Tax
-
2
114
56
19
39
Equity in Affiliates
11
4
7
8
14
14
Consolidated Net Income
117
175
31
25
309
153
Net Income
114
172
30
25
309
153
Net Income After Extraordinaries
114
172
30
25
309
153
Net Income Available to Common
115
172
30
25
309
153
EPS (Basic)
0.32
0.41
0.06
0.05
0.55
0.27
Basic Shares Outstanding
355
422
488
551
559
563
EPS (Diluted)
0.32
0.41
0.06
0.05
0.55
0.27
Diluted Shares Outstanding
355
422
488
551
559
563
EBITDA
57
97
45
55
168
64
Other Operating Expense
-
-
26
-
-
-
Non-Operating Interest Income
-
1
-
1
1
1
Minority Interest Expense
3
3
1
-
-
-
Preferred Dividends
-
-
-
-
-
-

About OPKO Health

View Profile
Address
4400 Biscayne Boulevard
Miami Florida 33137
United States
Employees -
Website http://www.opko.com
Updated 07/08/2019
OPKO Health, Inc. engages in the provision of healthcare services. It operates through the Diagnostics and Pharmaceuticals segments. The Diagnostics segment comprises clinical laboratory operations which acquired through the Bio-Reference and point-of-care operations.